Alkyl Amines Chemicals Ltd
Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.
- Market Cap ₹ 11,644 Cr.
- Current Price ₹ 2,277
- High / Low ₹ 2,735 / 1,805
- Stock P/E 78.7
- Book Value ₹ 248
- Dividend Yield 0.44 %
- ROCE 16.5 %
- ROE 12.3 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 19.0%
- Company has been maintaining a healthy dividend payout of 26.5%
Cons
- Stock is trading at 9.19 times its book value
- The company has delivered a poor sales growth of 11.2% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
366 | 446 | 476 | 484 | 501 | 616 | 846 | 993 | 1,242 | 1,542 | 1,683 | 1,441 | 1,431 | |
308 | 362 | 390 | 393 | 405 | 499 | 682 | 736 | 812 | 1,216 | 1,335 | 1,189 | 1,175 | |
Operating Profit | 58 | 85 | 87 | 91 | 95 | 118 | 164 | 257 | 430 | 326 | 348 | 252 | 256 |
OPM % | 16% | 19% | 18% | 19% | 19% | 19% | 19% | 26% | 35% | 21% | 21% | 17% | 18% |
1 | 2 | 2 | 2 | 1 | 2 | 4 | 40 | 6 | 14 | 9 | 14 | 14 | |
Interest | 13 | 12 | 10 | 8 | 8 | 8 | 15 | 10 | 6 | 3 | 3 | 4 | 4 |
Depreciation | 10 | 10 | 11 | 13 | 14 | 16 | 23 | 27 | 29 | 35 | 45 | 59 | 64 |
Profit before tax | 36 | 65 | 67 | 72 | 74 | 96 | 130 | 260 | 401 | 302 | 309 | 202 | 202 |
Tax % | 33% | 34% | 32% | 31% | 32% | 33% | 36% | 17% | 26% | 26% | 26% | 26% | |
24 | 43 | 45 | 50 | 50 | 64 | 84 | 215 | 295 | 225 | 229 | 149 | 148 | |
EPS in Rs | 4.69 | 8.41 | 8.91 | 9.77 | 9.87 | 12.61 | 16.42 | 42.21 | 57.91 | 44.04 | 44.75 | 29.12 | 28.95 |
Dividend Payout % | 21% | 19% | 18% | 41% | 20% | 22% | 20% | 19% | 17% | 23% | 22% | 34% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 11% |
3 Years: | 5% |
TTM: | -12% |
Compounded Profit Growth | |
---|---|
10 Years: | 13% |
5 Years: | 12% |
3 Years: | -20% |
TTM: | -25% |
Stock Price CAGR | |
---|---|
10 Years: | 31% |
5 Years: | 47% |
3 Years: | -17% |
1 Year: | 0% |
Return on Equity | |
---|---|
10 Years: | 25% |
5 Years: | 25% |
3 Years: | 19% |
Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 97 | 130 | 165 | 189 | 235 | 287 | 355 | 526 | 782 | 980 | 1,159 | 1,257 |
146 | 151 | 135 | 111 | 120 | 181 | 165 | 87 | 47 | 23 | 88 | 3 | |
79 | 98 | 93 | 95 | 147 | 159 | 218 | 160 | 306 | 359 | 335 | 314 | |
Total Liabilities | 332 | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 |
126 | 155 | 151 | 187 | 220 | 355 | 376 | 423 | 458 | 629 | 719 | 1,089 | |
CWIP | 9 | 3 | 31 | 16 | 35 | 18 | 43 | 45 | 138 | 143 | 352 | 36 |
Investments | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 30 | 0 | 0 | 0 |
195 | 229 | 218 | 201 | 256 | 262 | 328 | 315 | 520 | 600 | 521 | 459 | |
Total Assets | 332 | 388 | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
22 | 46 | 61 | 101 | 63 | 102 | 144 | 188 | 364 | 205 | 248 | 275 | |
-27 | -26 | -31 | -35 | -65 | -132 | -67 | -41 | -213 | -206 | -277 | -121 | |
5 | -13 | -36 | -68 | -2 | 32 | -60 | -135 | -86 | -57 | 8 | -140 | |
Net Cash Flow | 0 | 7 | -6 | -2 | -3 | 2 | 17 | 12 | 65 | -58 | -21 | 13 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 76 | 73 | 76 | 68 | 71 | 73 | 66 | 60 | 67 | 66 | 56 | 56 |
Inventory Days | 141 | 133 | 105 | 92 | 165 | 99 | 88 | 67 | 91 | 76 | 82 | 85 |
Days Payable | 73 | 79 | 58 | 63 | 120 | 78 | 104 | 57 | 133 | 105 | 84 | 85 |
Cash Conversion Cycle | 143 | 128 | 123 | 96 | 116 | 94 | 51 | 71 | 25 | 36 | 53 | 56 |
Working Capital Days | 105 | 96 | 93 | 87 | 84 | 76 | 56 | 54 | 34 | 40 | 46 | 47 |
ROCE % | 21% | 28% | 26% | 26% | 24% | 25% | 29% | 41% | 56% | 33% | 28% | 16% |
Documents
Announcements
-
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
2d - Board meeting to approve Q2 financial results.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Oct
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 27 Sep
- Closure of Trading Window 24 Sep
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
18 Sep - Allotment of 5,006 shares under ESOP 2018.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
Concalls
-
May 2024TranscriptPPTREC
-
May 2024TranscriptNotesPPTREC
-
Nov 2023TranscriptPPTREC
-
May 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
May 2022TranscriptPPT
-
Nov 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
Nov 2020TranscriptPPT
-
Jul 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
May 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Jun 2018TranscriptPPT
-
Nov 2017TranscriptPPT
-
Jun 2017TranscriptPPT
-
May 2016TranscriptPPT
Business Leadership
The co. offers 100+ products, it is a global leader in many products including acetonitrile, DEHA, DMA-HCLA, and Triethylamine. [1]